Back to HighTower Advisors, LLC HighTower Advisors, LLC

VTGNVTGN
8 quarters

Position history for HighTower Advisors, LLCHighTower Advisors, LLC's holdings in VISTAGEN THERAPEUTICS INC

HighTower Advisors, LLC holds 20,628 shares of VTGN (VISTAGEN THERAPEUTICS INC), worth $4,662 as of 2026-Q2.

Current Value

$4,662

Current Shares

20,628

Total Value Change

-$59,338

Total Shares Change

-200

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
20,628
0.0%
$4,6620.0%$0.23
0
2026-Q1
Unchanged
20,628
0.0%
$11,7890.0%$0.61
0
2025-Q4
Decreased
20,628
-1.0%
$13,6540.0%$0.68
0
2025-Q3
Unchanged
20,828
0.0%
$73,9390.0%$3.54
0
2025-Q2
Unchanged
20,828
0.0%
$41,6560.0%$1.97
0
2025-Q1
Unchanged
20,828
0.0%
$52,0700.0%$2.59
0
2024-Q4
Unchanged
20,828
0.0%
$61,4430.0%$2.81
0
2024-Q3
New
20,828
-
$64,0000.0%$3.07
29

Other major holders of VTGN: Janus Henderson Group Ltd., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used